Zegerid Dosage
Generic name: omeprazole and sodium bicarbonate
Drug class: Proton pump inhibitors
Medically reviewed by A Ras MD. Last updated Oct 6, 2022
Recommended Adult Dosing
Dosage forms: CAP: 20 mg/1100 mg, 40 mg/1100 mg; PWDR: 20 mg/1680 mg per pkt, 40 mg/1680 mg per pkt
Special Note
- [dosing clarification]
- Info: two 20 mg cap not bioequivalent to one 40 mg cap, two 20 mg pkt not bioequivalent to one 40 mg pkt due to sodium bicarbonate component; doses based on omeprazole component
GERD
- [non-erosive, symptomatic]
- Dose: 20 mg PO/NG qd x4-8wk; Info: give >1h before meals; do not open cap, see PPI Administration Alternatives table
- [erosive esophagitis, short-term tx]
- Dose: 20 mg PO/NG qd x4-12wk; Info: give >1h before meals; do not open cap, see PPI Administration Alternatives table
- [erosive esophagitis, maintenance tx]
- Dose: 20 mg PO/NG qd; Info: give >1h before meals; do not open cap, see PPI Administration Alternatives table
Duodenal ulcer
- [20-40 mg PO/NG qd x4-8wk]
- Info: usual maint. dose 20 mg qd; give >1h before meals; do not open cap, see PPI Administration Alternatives table
Gastric ulcer
- [40 mg PO/NG qd x4-8wk]
- Info: give >1h before meals; do not open cap, see PPI Administration Alternatives table
Upper GI bleeding prophylaxis, critically ill pts
- [40 mg NG/OG qd x14 days]
- Start: 40 mg NG/OG x1, then 40 mg NG/OG x1 6-8h later; Info: suspend tube feeding 3h before and 1h after; do not use cap; see PPI Administration Alternatives table
Gastric ulcer prophylaxis, NSAID-assoc.
- [20-40 mg PO/NG qd]
- Info: give >1h before meals; do not open cap, see PPI Administration Alternatives table
Hypersecretory conditions
- [individualize dose PO/NG qd-tid]
- Start: 60 mg PO/NG qd; Info: doses up to 120 mg PO tid have been used; divide doses >80 mg/day; give >1h before meals; do not open cap, see PPI Administration Alternatives table
Renal dosing
- renal impairment: no adjustment; Info: caution advised, sodium bicarbonate may cause sodium retention
- HD/PD: not defined
Hepatic dosing
- [erosive esophagitis, maintenance tx]
- hepatic impairment: avoid use
- [all other indications]
- hepatic impairment: not defined
SRC: NLM .